Results
Latest quarterly results
Companies that reported quarterly results recently, newest first. Each row compares the reported quarter with the same quarter a year earlier. Figures in USD; revenue and net income in millions.
SectorAll 2391Healthcare 703Technology 382Industrials 290Financial Services 229Consumer Cyclical 183Basic Materials 152Communication Services 124Energy 114Consumer Defensive 83Real Estate 80Utilities 51
| Company | Sector | Reported | Quarter | Revenue | Rev. YoY | Net income | NI YoY | EPS | EPS YoY | Op. margin | Margin chg. | Market cap |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MISTMilestone Pharmaceuticals Inc. | Healthcare | Nov 13 | Sep '26 | $3.0M | n/m | −$26.0M | n/m | −$0.18 | n/m | -845.5% | — | $51M |
| HOWLWerewolf Therapeutics, Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$10.0M | n/m | −$0.20 | n/m | — | — | $51M |
| PDSBPDS Biotechnology Corporation | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$8.0M | n/m | −$0.11 | n/m | — | — | $50M |
| MBOTMicrobot Medical Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | $1.0M | n/m | −$0.09 | n/m | — | — | $46M |
| ELOXEloxx Pharmaceuticals, Inc. | Healthcare | Nov 13 | Sep '26pending | — | — | — | — | — | — | — | — | $40M |
| IRLAIRulya Therapeutics Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$28.0M | n/m | −$2.31 | n/m | — | — | $39M |
| ONCYOncolytics Biotech Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$10.0M | n/m | −$0.08 | n/m | — | — | $38M |
| ANVSAnnovis Bio, Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$9.46B | n/m | −$0.22 | n/m | — | — | $32M |
| EXOZeXoZymes Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$2.0M | n/m | −$0.24 | n/m | — | — | $31M |
| AARDAardvark Therapeutics, Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$19.0M | n/m | −$0.88 | n/m | — | — | $25M |
| MLSSMilestone Scientific, Inc. | Healthcare | Nov 13 | Sep '26 | $2.0M | 0.0% | −$1.0M | n/m | −$0.01 | n/m | -33.6% | +14.4 pp | $25M |
| BYSIBeyondSpring, Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$3.0M | n/m | −$0.07 | n/m | — | — | $23M |
| TXMDTherapeuticsMD, Inc. | Healthcare | Nov 13 | Sep '26 | $1.0M | 0.0% | $0.0M | n/m | $0.04 | +300.0% | -38.0% | +67.8 pp | $22M |
| ENLVEnlivex Ltd. | Healthcare | Nov 13 | Sep '26pending | — | — | — | — | — | — | — | — | $19M |
| KTTAPasithea Therapeutics Corp. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$7.0M | n/m | −$0.20 | n/m | — | — | $15M |
| COSMCosmos Health Inc. | Healthcare | Nov 13 | Sep '26pending | — | — | — | — | — | — | — | — | $14M |
| TVRDTvardi Therapeutics, Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$6.0M | n/m | −$0.48 | n/m | — | — | $13M |
| ALLRAllarity Therapeutics, Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$6.0M | n/m | −$0.39 | n/m | — | — | $13M |
| PAVMPAVmed Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$13.0M | n/m | −$1.77 | n/m | — | — | $12M |
| OPTHOptimi Health Corp. | Healthcare | Nov 13 | Sep '26pending | — | — | — | — | — | — | — | — | $12M |
| FEMYFemasys Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | −100.0% | −$5.0M | n/m | −$0.53 | n/m | — | — | $9M |
| LSTALisata Therapeutics, Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$7.0M | n/m | −$0.73 | n/m | — | — | $9M |
| GDTCCytoMed Therapeutics Limited | Healthcare | Nov 13 | Sep '26pending | — | — | — | — | — | — | — | — | $9M |
| BFRIBiofrontera Inc. | Healthcare | Nov 13 | Sep '26 | $9.0M | +28.6% | −$6.0M | n/m | −$0.42 | n/m | -71.6% | +18.2 pp | $9M |
| VTGNVistagen Therapeutics, Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$11.0M | n/m | −$0.24 | n/m | — | — | $8M |
| MTVAMetaVia Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$5.0M | n/m | −$0.69 | n/m | — | — | $8M |
| BFRGBullfrog AI Holdings, Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$2.0M | n/m | −$0.11 | n/m | — | — | $8M |
| CURXCuranex Pharmaceuticals Inc | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$3.0M | n/m | −$1.86 | n/m | — | — | $7M |
| MBRXMoleculin Biotech, Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$6.0M | n/m | −$9.59 | n/m | — | — | $7M |
| TPSTTempest Therapeutics, Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$4.0M | n/m | −$0.21 | n/m | — | — | $7M |
| ENVBEnveric Biosciences, Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$3.0M | n/m | −$0.57 | n/m | — | — | $6M |
| CABRCaring Brands, Inc. | Healthcare | Nov 13 | Sep '26 | — | — | −$1.0M | n/m | −$0.08 | n/m | — | — | $6M |
| ACTUActuate Therapeutics, Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$3.0M | n/m | −$0.14 | n/m | — | — | $6M |
| LFWDLifeward Ltd. | Healthcare | Nov 13 | Sep '26 | $5.0M | −16.7% | −$5.0M | n/m | −$1.32 | n/m | -110.0% | −59.3 pp | $5M |
| PCSAProcessa Pharmaceuticals, Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$183M | n/m | −$61.58 | n/m | — | — | $5M |
| CNSYCerenome, Inc. | Healthcare | Nov 13 | Sep '26 | $1.0M | 0.0% | −$9.0M | n/m | −$1.14 | n/m | — | — | $5M |
| SCNXScienture Holdings, Inc. | Healthcare | Nov 13 | Sep '26 | $1.25B | +125,400% | −$6.01B | n/m | −$3.76 | n/m | -437.5% | +301.6 pp | $5M |
| SKYESkye Bioscience, Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | $0.0M | n/m | $0.01 | n/m | — | — | $4M |
| GRIGRI Bio, Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$2.0M | n/m | −$0.69 | n/m | — | — | $3M |
| MEDSDataMeds AI, Inc. | Healthcare | Nov 13 | Sep '26pending | $2.7M† | +166.9% | — | — | — | — | — | — | $3M |
| HCTIHealthcare Triangle, Inc. | Healthcare | Nov 13 | Sep '26 | $9.0M | +200.0% | −$3.0M | n/m | −$4.08 | n/m | -21.9% | +52.3 pp | $3M |
| CLDICalidi Biotherapeutics, Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$4.0M | n/m | −$1.47 | n/m | — | — | $2M |
| PPCBPropanc Biopharma, Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$9.0M | n/m | −$12.22 | n/m | — | — | $2M |
| SILOSilo Pharma, Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | $0.0M | n/m | −$0.21 | n/m | — | — | $2M |
| XRTXXORTX Therapeutics Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | $0.0M | n/m | −$0.21 | n/m | — | — | $2M |
| PFSAProfusa, Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$5.0M | n/m | −$6.23 | n/m | — | — | $2M |
| KAPAKairos Pharma, Ltd. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$2.0M | n/m | −$0.59 | n/m | — | — | $1M |
| ELABPMGC Holdings Inc. | Healthcare | Nov 13 | Sep '26 | $3.0M | n/m | −$2.0M | n/m | −$3.01 | n/m | -97.8% | +669.7 pp | $1M |
| ASBPAspire-Lakewood Holdings, Inc. | Healthcare | Nov 13 | Sep '26pending | — | — | — | — | — | — | — | — | $957,588 |
| GNPXGenprex, Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$4.0M | n/m | −$5.30 | n/m | — | — | $843,494 |
- Report dates come from the earnings calendar (dates loaded Oct 4 to Dec 9); figures come from the quarterly statements stored for each company. Click a ticker for its full statements.
- YoY compares the reported quarter with the same quarter a year earlier. n/m (not meaningful) means the year-earlier figure was zero or negative, so a percentage change would not describe it. Margin change is in percentage points.
- pending: the company has reported, but that quarter is not in our statements yet. Revenue marked † is the announced figure from the earnings calendar; the other columns fill in once the statements update.
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.